AstraNu raises $3.5M Seed to commercialize chip-scale optical imaging engine

AstraNu raises $3.5M Seed to commercialize chip-scale optical imaging engine

Latest Medtech News


AstraNu, a Nokia Bell Labs spin-out based in Murray Hill, New Jersey, has closed a $3.5 million seed round led by Celesta Capital, with co-investment from the New Jersey Innovation Evergreen Fund. The company describes its product as the first chip-scale optical coherence tomography (OCT) imaging engine for the medical device industry.

As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Subscribe to our Industry Insights for weekly coverage.

Swept-source OCT can image faster and deeper than spectral-domain OCT, but its cost and size have limited where it can be used. AstraNu says its engine delivers swept-source performance at spectral-domain price points, in a module more than 10 times smaller and significantly cheaper than conventional swept-source systems. The company supplies the engine to medical device, imaging and optics companies that want to build OCT into their own products. Ophthalmology is the first target, and it is also working with developers in ENT, urology and oncology.

The funding will go toward building the photonics team, validating the engine’s performance and preparing for volume manufacturing. AstraNu says it is ready to demonstrate the technology with application partners. President and General Manager Kevin Blalock said the round gives the company “the runway” to get its engine into partner testbeds.

For the broader MedTech space, the company reflects a model of supplying an imaging component to device makers, not building finished devices. It first showed the technology in middle-ear imaging.

Go Back

We'd love to hear what you're building